RNS Number : 2247X
Convatec Group PLC
29 August 2025
29 August 2025
Convatec Group Plc
("Convatec" or "the Company")
Director/PDMR Shareholding
Purchase of Ordinary Shares
The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").
On 28 August 2025, Jonny Mason, Interim Chief Executive Officer, purchased 50,000 Shares at an average price of 234.81 pence per Share.
On the same day, Fiona Ryder, Interim Chief Financial Officer purchased 21,263 Shares at an average price of 233.96 pence per Share.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Jonny Mason
2
Reason for the notification
a)
Position/status
Interim Chief Executive Officer and PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Convatec Group Plc
b)
LEI
213800LS272L4FIDOH92
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£2.3481
50,000
d)
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e)
Date of the transaction
28 August 2025
f)
Place of the transaction
London Stock Exchange
Details of the person discharging managerial responsibilities / person closely associated
Name
Fiona Ryder
Reason for the notification
Position/status
Interim Chief Financial Officer and PDMR
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Convatec Group Plc
LEI
213800LS272L4FIDOH92
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary share of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
Nature of the transaction
Purchase of Ordinary Shares
Price(s) and volume(s)
Price(s)
Volume(s)
£2.3396
21,263
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
Date of the transaction
28 August 2025
Place of the transaction
London Stock Exchange
Contacts
The person responsible for making this announcement is James Kerton, Company Secretary, Convatec Group plc: cosec@convatec.com
Media: MediaRelations@convatec.com
Investor Relations: IR@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFIFITTDIAFIE
